JPRN-C000000055
Completed
Phase 3
Phase III Randomized Adjuvant Study of Chemotherapy in Node Positive Breast Cancer Patients -AC(Anthracycline-Cyclophosphamide) 4 cycles followed by Taxane 4 cycles (AC-Tac) versus Taxane 8 cycles and Paclitaxel versus Docetaxel- - Phase III Randomized Adjuvant Study of chemotherapy in Node Positive Breast Cancer Patients (N-SAS BC 02)
-SAS BC 02 executive committee0 sites1,200 target enrollmentAugust 12, 2005
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- -SAS BC 02 executive committee
- Enrollment
- 1200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)During pregnancy or lactation (2\)Double invasive carcinoma(less than 5 years after the last treatment) (3\)Metachronous bilateral breast cancer (4\)Anaphylaxis against medicine using cremophor EL(polyoxethylated castor oil) or polysorbate as a solvent (5\)Patients judged inappropriate for this study by the physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Randomized phase III study of adjuvant chemotherapy with combination therapy of gemcitabine and S-1 vs. gemcitabine alone in patients with resected pancreatic cancer (JSAP-04)Resected pancreatic cancerJPRN-UMIN000004410Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP)300
Recruiting
Not Applicable
Phase III Randomized Trial of Adjuvant Chemotherapy with TS-1 vs TS-1/oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II TrialKCT0003993Samsung Medical Center900
Completed
Phase 3
A Randomized Phase III Trial of Adjuvant Chemotherapy with UFT following Curative Radiation Therapy for Locally Advanced Cervical CancerStage Ib2-IVa cervical cancer with Curative Radiation TherapyJPRN-UMIN000003651Gynecologic Oncology Trial and Investigation Consortium350
Completed
Not Applicable
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryPER-155-08EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),
Active, not recruiting
Not Applicable
A trial to compare chemotherapy + bevacizumab and chemotherapy alone in patients with resected lung cancer (called non-small cell lung cancer)EUCTR2007-003195-19-IEICORG1,500